Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for CSF3R T618I Mutant Chronic Neutrophilic Leukemia

Turk J Haematol. 2023 Feb 28;40(1):73-74. doi: 10.4274/tjh.galenos.2022.2022.0400. Epub 2022 Dec 13.

Authors

Peipei Ye¹, Qingqing Lin¹, Mingwei Jin¹, Xin Gu¹, Ying Lu¹

Affiliation

¹ The Affiliated People’s Hospital of Ningbo University, Department of Hematology, Ningbo, Zhejiang, China

No abstract available

Keywords: CSF3R T618I; Chronic neutrophilic leukemia; Ruxolitinib; Allogenic stem cell transplantation.

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Neutrophilic, Chronic* / genetics
Leukemia, Neutrophilic, Chronic* / therapy
Mutation
Nitriles
Receptors, Colony-Stimulating Factor / genetics
Stem Cell Transplantation

Substances

ruxolitinib
Nitriles
CSF3R protein, human
Receptors, Colony-Stimulating Factor